Table 2.
Morphometric measurements and cardiovascular risk factors of the Filipino-American women participants (n = 235).
| Measurement | Means ± SD | Percent of group (risk level) |
|---|---|---|
| Weight (lbs.) | 151 ± 22 | |
| Height (inches) | 61 ± 2 | |
| Body mass index | 29 ± 4 | 37 (≥25 kg/m2) 15 (≥30 kg/m2) |
| Waist circumference | 40 ± 4 | 79 (≥35 inches) |
| Systolic blood pressure | 131 ± 19 | 64 (≥120 mmHg) |
| Diastolic blood pressure | 87 ± 10 | 61 (≤80 mmHg) |
| Fasting blood glucose | 101 ± 25 | 38 (≥100 mg/dL) |
| Hemoglobin A1C | 6.0 ± 0.8 | 36 (≥6.5%) |
| Total cholesterol | 201 ± 45 | 44 (≥200 mg/dL) |
| Triglycerides | 116 ± 67 | 19 (≥150 mg/dL) |
| Low-density lipoprotein-C | 122 ± 35 | 61 (≥100 mg/dl) |
| High-density lipoprotein-C | 62 ± 15 | 21 (≤50 mg/dL) |
| High-Sensitivity C-Reactive protein |
1.97 ± 3.0 | 13 (<3.0 mg/L) |
| Metabolic syndrome | 56 | |
| Smoking | 3 | |
| Family history | 48 |
Note: metabolic syndrome was defined by both the International Diabetes Federation (IDF) and the National Cholesterol Education Program—Adult Treatment Panel III (NCEP/ATP III) criteria.